Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for PRPO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -0.057M
March 31, 2026 -0.061M
December 31, 2025 0.055M
September 30, 2025 1.219M
June 30, 2025 -0.181M
March 31, 2025 -0.19M
December 31, 2024 -0.185M
September 30, 2024 -0.158M
June 30, 2024 0.073M
March 31, 2024 -0.059M
December 31, 2023 -0.125M
September 30, 2023 -0.092M
June 30, 2023 1.666M
March 31, 2023 0.293M
December 31, 2022 -0.147M
September 30, 2022 0.031M
June 30, 2022 -0.046M
March 31, 2022 -0.063M
December 31, 2021 -0.097M
September 30, 2021 -0.046M
June 30, 2021 15.31M
March 31, 2021 1.104M
December 31, 2020 1.979M
September 30, 2020 4.282M
June 30, 2020 1.895M
Date Value
March 31, 2020 1.182M
December 31, 2019 1.311M
September 30, 2019 2.647M
June 30, 2019 3.902M
March 31, 2019 1.803M
December 31, 2018 2.146M
September 30, 2018 1.36M
June 30, 2018 2.29M
March 31, 2018 1.015M
December 31, 2017 2.392M
September 30, 2017 2.998M
June 30, 2017 1.404M
March 31, 2017 0.308M
December 31, 2016 0.30M
September 30, 2016 0.123M
June 30, 2016 -1.376M
March 31, 2016 1.728M
December 31, 2015 0.008M
September 30, 2015 2.033M
June 30, 2015 -0.343M
March 31, 2015 7.293M
December 31, 2014 3.079M
September 30, 2014 0.01M
June 30, 2014 2.91M
March 31, 2014 4.071M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
NeoGenomics, Inc. -12.24M
Quest Diagnostics, Inc. -229.00M
Labcorp Holdings, Inc. -919.90M
OPKO Health, Inc. -13.03M
Psychemedics Corp. --